| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.0062 | 1 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |